NOVAVAX Announces Contract Award from U.S. Department of Homeland Security to Develop Foot-and-Mouth Disease Vaccine
05 oct. 2011 08h00 HE
|
Novavax, Inc.
ROCKVILLE, Md., Oct. 5, 2011 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced that it has been awarded a $1.3 million contract from the U.S. Department of Homeland Security to develop a...
NOVAVAX Reports Positive Results From Phase I Trial of Respiratory Syncytial Virus Vaccine Candidate
03 oct. 2011 08h00 HE
|
Novavax, Inc.
- Well-tolerated with no systemic side-effect trends
- Highly immunogenic with an increase in anti-RSV antibodies in 100% of subjects in the highest-dose group
- Oral and poster...
Novavax to Report Top-Line Results From Phase I Respiratory Syncytial Virus Vaccine Clinical Trial on October 3rd at 5th Vaccine and ISV Annual Global Conference
26 sept. 2011 08h00 HE
|
Novavax, Inc.
ROCKVILLE, Md., Sept. 26, 2011 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced that it will report top-line results from a Phase I clinical trial of its respiratory syncytial virus...
NOVAVAX Announces Publication of Results From H5N1 Influenza Virus-Like Particle Vaccine Phase I/IIa Clinical Trial
08 sept. 2011 08h00 HE
|
Novavax, Inc.
VLP vaccine candidate was well-tolerated, immunogenic and generated cross-reactive neutralizing antibodies
ROCKVILLE, Md., Sept. 8, 2011 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) announced...
NOVAVAX to Present at Stifel Nicolaus Healthcare Conference
06 sept. 2011 13h59 HE
|
Novavax, Inc.
ROCKVILLE, Md., Sept. 6, 2011 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), a clinical-stage vaccine company, announced today that Stanley C. Erck, President and Chief Executive Officer of Novavax,...
Novavax to Present at the 2011 Wedbush Life Sciences Conference
16 août 2011 08h00 HE
|
Novavax, Inc.
ROCKVILLE, Md., Aug. 16, 2011 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) a clinical-stage vaccine company, announced today that Stanley C. Erck, President and Chief Executive Officer of Novavax,...
Novavax Reports Second Quarter 2011 Financial Results
05 août 2011 08h00 HE
|
Novavax, Inc.
ROCKVILLE, Md., Aug. 5, 2011 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced financial results for the second quarter ended June 30, 2011.
Novavax reported a net loss of $5.0...
NOVAVAX and the Mexican Social Security Institute Publish Results From H1N1 Influenza Vaccine Trial in Mexico
04 août 2011 09h13 HE
|
Novavax, Inc.
ROCKVILLE, Md., Aug. 4, 2011 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) and Specialties Hospital of the National Medical Center, Mexico City, today announced the publication of safety and...
Novavax to Report Second Quarter 2011 Financial Results on August 5, 2011
29 juil. 2011 15h51 HE
|
Novavax, Inc.
ROCKVILLE, Md., July 29, 2011 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) will report financial results for the second quarter of 2011 on Friday, August 5, 2011, before the U.S. financial markets...
Novavax Appoints Dr. Timothy Hahn Senior Vice President of Manufacturing
28 juin 2011 08h00 HE
|
Novavax, Inc.
ROCKVILLE, Md., June 28, 2011 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) announced today the appointment of Timothy J. Hahn, Ph.D., as Senior Vice President of Manufacturing. Dr. Hahn will...